BMRA (BIOMERICA INC) Stock Analysis - AI Report

BIOMERICA INC (BMRA) is a publicly traded Healthcare sector company. As of May 21, 2026, BMRA trades at $2.35 with a market cap of $6.95M and a P/E ratio of -0.93. BMRA moved +0.00% today. Year to date, BMRA is -9.62%; over the trailing twelve months it is -35.44%. Its 52-week range spans $1.87 to $10.16. Rallies surfaces BMRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on BMRA?

Rallies AI research for BMRA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

BMRA Key Metrics

Key financial metrics for BMRA
MetricValue
Price$2.35
Market Cap$6.95M
P/E Ratio-0.93
EPS$-2.49
Dividend Yield0.00%
52-Week High$10.16
52-Week Low$1.87
Volume0
Avg Volume0
Revenue (TTM)$4.46M
Net Income$-4.03M
Gross Margin5.61%

Latest BMRA News

Recent BMRA Insider Trades

  • Irani Zackary S. bought 200 (~$310) on May 25, 2023.
  • Irani Zackary S. bought 500 (~$805) on May 24, 2023.
  • Irani Zackary S. bought 1.70K (~$1.99K) on May 12, 2023.

BMRA Analyst Consensus

BMRA analyst coverage data. Average price target: $0.00.

Common questions about BMRA

What is the AI research view on BMRA?
Rallies AI research for BMRA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for BMRA?
Rallies AI research for BMRA combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is BMRA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BMRA. It does not provide personalized investment advice.
BMRA

BMRA